Novavax reported $-316390000 in Pre-Tax Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Adamas Pharmaceuticals ADMS:US -19518000 7.17M
Adma Biologics ADMA:US $ -17.71M 0.39M
AstraZeneca AZN:LN 1954M 415M
Genocea Biosciences GNCA:US $ -3.62M 0.69M
Geron GERN:US $ -26.7M 2.88M
Kindred Biosciences KIN:US $ -9.13M 0.61M
Mannkind MNKD:US $ -4.43M 31.1M
Minerva Neurosciences NERV:US $ -9.2M 1.38M
Moderna Inc MRNA:US 3.55B 489M
Novartis NVS:US $ 4544M 120M
Novavax NVAX:US $ -316.39M 32.38M
Peregrine Pharmaceuticals PPHM:US $ 6.3M 4.31M
Sarepta Therapeutics SRPT:US $ -47.91M 33.85M
Tg Therapeutics TGTX:US $ -85.64M 7.14M